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A leucine to alanine substitution (L9A) was introduced in the M2 region of the mouse 4 neuronal nicotinic acetylcholine receptor
(nAChR) subunit. Expressed in Xenopus oocytes, 4(L9A)2 nAChRs were30-fold more sensitive than wild type (WT) to both ACh
and nicotine. We generated knock-in mice with the L9A mutation and studied their cellular responses, seizure phenotype, and sleep–
wake cycle. Seizure studies on 4-mutated animals are relevant to epilepsy research because all known mutations linked to autosomal
dominant nocturnal frontal lobe epilepsy (ADNFLE) occur in the M2 region of 4 or2 subunits. Thalamic cultures and synaptosomes
fromL9Amicewere hypersensitive to nicotine-induced ion flux. L9Amicewere15-foldmore sensitive to seizures elicited bynicotine
injection than their WT littermates. Seizures in L9A mice differed qualitatively from those in WT: L9A seizures started earlier, were
prevented by nicotine pretreatment, lacked EEG spike-wave discharges, and consisted of fast repetitive movements. Nicotine-induced
seizures in L9A mice were partial, whereas WT seizures were generalized. When L9A homozygous mice received a 10 mg/kg nicotine
injection, there was temporal and phenomenological separation of mutant andWT-like seizures: an initial seizure20 s after injection
was clonic and showed no EEG changes. A second seizure began 3–4 min after injection, was tonic-clonic, and had EEG spike-wave
activity. No spontaneous seizures were detected in L9A mice during chronic video/EEG recordings, but their sleep–wake cycle was
altered. Our findings show that hypersensitive 4* nicotinic receptors in mice mediate changes in the sleep–wake cycle and nicotine-
induced seizures resembling ADNFLE.
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Introduction
Stimulation of nicotinic acetylcholine receptors (nAChRs) by
nicotine triggers a wide range of physiological and behavioral
responses, including self-administration, hypothermia, sedation,
decreased nociception, increased alertness and locomotion, and
at higher doses, violent seizures and death. Questions regarding
the specific role of nicotinic receptors are now being addressed:
which nicotinic receptor subtypes are responsible for each of the
different responses? Where in the brain are the relevant cholin-
ergic pathways? Which responses depend on nicotinic receptor
activation, which on desensitization, and which on both?
Nicotinic receptors also figure in several CNS diseases. Auto-
somal dominant nocturnal frontal lobe epilepsy (ADNFLE) pro-
vides an excellent opportunity to study the link between changes
in the structure–function relationships of a specific receptor sub-
type and the mechanisms underlying a disease. Some cases of
ADNFLE are associated with point mutations in the M2 pore-
forming region of both 4 and 2 subunits of the nAChR (for
review, see Steinlein, 2004), which combine to form the predom-
inant heteromeric nAChR subtype in the brain (Whiting and
Lindstrom, 1988; Wada et al., 1989). Similar clinical symptoms
(frequent, brief, and sometimes violent partial seizures, starting
during childhood and occurring in sleep) are shared by all five
ADNFLE alleles isolated from different kindreds (Phillips et al.,
1995; Steinlein et al., 1995, 1997; Hirose et al., 1999; De Fusco et
al., 2000).
The epileptogenic mechanisms in 4- or 2-associated AD-
NFLE remain uncertain. Thus far, experimental analysis of AD-
NFLEmutations has been performed using heterologous expres-
sion of nAChRs in Xenopus oocytes and clonal cell lines. In these
reports, ADNFLE mutations in the 4 subunit increase ACh af-
finity (Steinlein et al., 1997), reduce Ca2 permeability (Kurya-
tov et al., 1997), decrease Ca2 potentiation (Figl et al., 1998;
Rodrigues-Pinguet et al., 2003), or enhance desensitization (Ber-
trand et al., 1998; Matsushima et al., 2002). ADNFLE mutations
in 2 lead to altered ACh sensitivity (Phillips et al., 2001) and/or
prolonged ACh-induced currents (De Fusco et al., 2000). An
attractive hypothesis arises from the findings that most or all of
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the knownADNFLEmutations, when expressed in oocytes, cause
an increase in ACh sensitivity (Bertrand et al., 2002), possibly by
decreasing Ca2 dependence (Rodrigues-Pinguet et al., 2003).
We have generated mutated mouse lines that express hyper-
sensitive 4* receptors (Labarca et al., 2001; Fonck et al., 2003;
Tapper et al., 2004). These knock-in mice contain mutations at
the Leu9 position in the M2 region of the nAChR 4 subunit; as
a result, 4* receptors respond to relatively low agonist concen-
trations. The Leu9Ala (L9A) strain in particular appears to iso-
late and amplify nicotine responses caused by 4* receptors. At
the lowest nicotine doses that we have tested, the L9A strain is a
goodmodel for some aspects of nicotine addiction (Tapper et al.,
2004). At higher doses, but still well below the seizure threshold
for WT mice, we find that nicotine causes seizures in L9A mice.
The present study examines activation, desensitization, and rela-
tive permeability properties of the 4 L9A mutation when ex-
pressed in oocytes.We also studied42 receptor expression and
function in forebrain tissue of L9A and wild-type (WT) mice.
We then investigated the seizure phenotype of L9A mice.
Materials andMethods
L9Amutation expressed inXenopus oocytes. Stage V–VIXenopus oocytes
were surgically isolated using a previously published protocol (Quick and
Lester, 1994). All surgeries were performed using methods approved by
the Institutional Animal Care Committee. Female Xenopus frogs were
anesthetized by immersion in 0.2% tricaine methanesulphonate. WT
mouse 4 and 2 nicotinic subunits were subcloned into the pCI-Neo
vector. The Quikchange kit (Stratagene, La Jolla, CA) was used to con-
struct4 L9A and4 Leu9Ser (L9S)mutations, whichwere verified by
DNA sequencing. Capped cRNA was synthesized from linearized cDNA
using the mMessage mMachine RNA transcription kit (Ambion, Austin,
TX). Isolated oocytes were injected with 4 ng of mouse 4 and 6 ng of
mouse2 cRNA in 50 nl of H2O. Before recording, injected oocytes were
incubated for 2 d in a solution containing the following (inmM): 96NaCl,
5 HEPES, 2.5 Na pyruvate, 2 KCl, 1.8 CaCl2, 1 MgCl2, 2.5 g/ml genta-
mycin, and 5% horse serum, pH 7.4 (at 18°C). Unless otherwise speci-
fied, all chemicals were obtained from Sigma-Aldrich (St. Louis, MO).
We used an automated two-electrode voltage-clamp (OpusXpress; Axon
Instruments, Union City, CA) to measure the agonist-induced currents
in injected oocytes at60 mV. During recordings, oocytes were contin-
ually superfused with a nominally Ca2-free saline (ND98) containing
(inmM) 98NaCl, 5HEPES, and 1MgCl2, pH 7.4, to prevent activation of
the endogenous Ca2-activated Cl current. Nicotine and ACh were
bath applied at a rate of 0.25 ml/s, with a chamber volume of 2 ml.
Oocytes with leak currents in ND98 larger than 300 nA were discarded.
Agonist concentration–response data were analyzed as described previ-
ously (Cohen et al., 1995). EC50 values, IC50 values, and Hill coefficient
errors calculated in all oocyte experiments were obtained by fitting these
parameters to the mean of normalized concentration-dependence data.
Nicotine-induced desensitization. Similar to Katz and Thesleff (1957),
we used periodic ACh test pulses to measure nicotine-induced steady-
state desensitization of WT and L9A mutant receptors expressed in
Xenopus oocytes. Receptor desensitization is manifested by a decrease in
the amplitude of ACh responses during sustained nicotine exposure. We
applied a total of 13 test pulses, 2.5 s in duration at 120 s intervals, to each
oocyte using a U-tube microperfusion system (Cohen et al., 1995). Nic-
otine was bath applied immediately after the third pulse. Five ACh test
pulses were delivered during nicotine bath perfusion and fivemore after.
The microperfusate contained 200 nM ACh plus nicotine (equal to the
bath-applied nicotine concentration) during nicotine superfusion. In the
absence of nicotine, the WT ACh test-pulse response remained constant
during the 13 applications. In contrast, the peak L9A ACh test-pulse
response increased linearly by 1.3  0.3% min1 (n  4 oocytes), pre-
sumably because of increased surface receptor expression. The WT data
were recorded 4–6 d after cRNA injections, and L9A recordings were
obtained 1–2 d after cRNA injections. Thus, surface receptor expression
apparently stabilized in WT but not in L9A experiments. To correct for
this increase, we divided the peak amplitude of the L9A test-pulse re-
sponses by a factor of (1 0.013t), where t is time in minutes since the
first test pulse. Steady-state receptor desensitization was estimated using
a decreasing exponential fit that included ACh pulses 3 through 8. The
first of these six AChpulses was applied immediately before nicotine, and
the last one was applied immediately before switching to nicotine-free
solution. The nicotine-induced current was subtracted from the peak
test-pulse response to obtain the ACh-induced peak current. Responses
during nicotine application were also normalized to the first peak test-
pulse response immediately before nicotine bath application.We plotted
the six peak test-pulse responses against their time of application and fit
the data to the sum of a decreasing exponential and a constant term to
obtain the steady-state fraction of undesensitized receptors (SSF). To
estimate the half-maximal inhibitory concentration (IC50), we fit the
nicotine concentration–response relationship for steady-state desensiti-
zation to a sigmoidal inhibitory function:
SSF
1
1 NicIC50 
nH ,
where [Nic] is the bath-applied nicotine concentration, and nH is the
apparent Hill coefficient for desensitization.
Permeabilitymeasurements.Wealso used the oocyte expression system
to measure the permeability of WT and L9A mutant receptors to Na
and Ca2 relative to K (PNa/PK, PCa/PK). Permeability estimates were
based on shifts in the reversal potential (Er) of the ACh response after
external ion substitutions. An ACh-induced current–voltage ( I–V) rela-
tionship was obtained by ramping the membrane potential from80 to
50 mV (Na, K) or50 to 30 mV (Ca2) in the presence and absence
of ACh anddigitally subtracting theACh-induced current from the back-
ground current. Voltage ramps were 0.5 s in duration and ACh was bath
applied.We allowed the ACh response to reach steady state before apply-
ing the ramps and used ACh concentrations in the lower half of the ACh
concentration–response relationship to minimize desensitization (5 M
ACh for WT, 10 or 100 nM ACh for L9A). The Er of the ACh-induced
current was obtained by fitting the following equation to the I–V rela-
tionship between20 and 20 mV:
IACh c a	1e
kV
,
whereV is themembrane potential inmillivolts, IACh is the ACh-induced
current in nanoamperes, a is the amplitude of the exponential compo-
nent, c is a constant, and k is a rate constant. To measure the PNa/PK, we
replaced all of the extracellular Na (98 mM) with equimolar K and
measured the shift in the Er of the ACh response. The PNa/PK was calcu-
lated using the following equation:
PNa
PK
 e
	Er 	Na
Er 	K


25 mV ,
where the Er(Na) and Er(K) are the Er values for the ACh response in 98
mMNa and K solutions, respectively, and 25 mV is the value of RT/F
at room temperature (20°C). To estimate PCa/PK, oocytes were injected
with 50 nl of a 100mMBAPTA-K4 solution 2 h before recordings to avoid
activating endogenous Ca2-dependent Cl currents. Wemeasured the
Er for the ACh response in an isosmotic Ca
2 solution containing 65mM
CaCl2 and, assuming that K
was the sole intracellular permeant cation,
calculated PCa/PK from the following equation (Fatt and Ginsborg,
1958):
PCa
PK

K i
4 Ca2 o
e	Er 	Ca
/ 25 mV
	1 e	Er 	Ca
/ 25 mV

,
where [K]i is the apparent intracellular K
 concentration, [Ca2]o is
the extracellular Ca2 concentration, and Er(Ca) is the Er for the ACh-
induced current in Ca2. [K]i in this equation was calculated from the
pooled WT and L9A Er(K), using the Nernst equation, assuming that
K was the sole intracellular permeant cation. All external solutions
contained 1 mM MgCl2 and 5 mM HEPES, pH 7.5, in addition to the
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cations mentioned above. Extracellular solutions for Na and K re-
placement contained no added Ca2.
Generation of L9A knock-in mice. This section reproduces the on-line
supplemental material in Tapper et al. (2004). L9A construct design and
embryonic stem (ES) cell manipulation was similar to that used in the
generation of the L9S mouse line (Labarca et al., 2001). Previous work
generated a 129/SvJ 4 genomic clone containing exon 5 with the L9S
mutation in the vector pKO Scrambler V907 (Labarca et al., 2001). A
neomycin resistance cassette with a phosphoglycerate kinase promoter
and polyadenylation signal (Neo) flanked by loxP sites was present 163
bp downstream from exon 5 for positive selection. The diphtheria toxin
A chain gene with an RNA polymerase II promoter was also added to
provide negative selection for random insertion.
A 4.1 kb cassette containing exon 5 was removed from the pKO vector
via digestion with SpeI and inserted into pBlueScript (Stratagene) for
modification. PCRmutagenesis using theQuikchange Site-directedMu-
tagenesis kit was used to replace the L9S mutation with the L9A muta-
tion (codon changed from TCT to GCT). The presence of the mutation
was confirmed by automated sequence analysis. A small 250 bp cassette
containing the L9A mutation was subsequently cut out from pBlue-
Script with BsrGI and BglII and then unidirectionally ligated into pBlue-
Script L9S 4 exon 5. This was done to avoid sequencing the entire 4.1
kb exon 5 cassette that went through PCR amplification. The 4.1 exon 5
cassette was then removed by digestion with SpeI and ligated back into
the knock-in construct. Clones in the correct orientation yielded two
fragments, 8 and 7 kb in length, during digestionwithNsiI (as opposed to
10 and 5 kb fragments in the wrong orientation). The 4 L9A knock-in
construct was linearized with NotI and chloroform/phenol extracted in
preparation for introduction into mouse ES cells.
CJ7 mouse ES cells were electroporated with 25 g of linearized
knock-in construct. Six rounds of electroporation were performed using
107 ES cells/electroporation. After electroporation, each group of cells
was plated on 10 cm dishes containing single layers of mitotically inacti-
vatedmouse primary fibroblasts. To select for recombinant clones, G418
(180 g/ml) was applied to ES cells 24 h after plating. Cell death was
apparent 3 d after treatment. After 7 d of G418 treatment, 600 resistant
colonies were picked and plated onto 96-well plates, grown for 48 h,
trypsinized, and then split onto duplicate plates, one for freezing and the
other for screening. Correct recombinant colonies were screened for the
presence of theNeo cassette and L9Amutation by a combination of PCR
and automated sequence analysis. DNA for PCR and sequencing was
isolated by applying lysis buffer (in mM: 10 Tris, pH 7.5, 10 EDTA, 10
NaCl, 1% SDS, and 1 mg/ml proteinase K) to cells and incubating over-
night at 60°C, followed by ethanol precipitation. To confirm the position
of the Neo cassette, ES cells were screened via Southern blot. Positive
clones were sequenced to verify the presence of the L9A mutation.
Karyotype analysis was used to assess chromosome number. Two posi-
tive clones with the highest percentage of proper chromosome number
(90%) were selected for the subsequent round of electroporation.
The Neo cassette was excised by electroporating two clones of the
Neo-intact L9A 4 ES cells with cytomegalovirus Cre plasmid, leaving
only a single 34 bp loxP. Electroporation was performed as described
above. Cells were plated (400 cells per plate) onto 10 cm dishes contain-
ing single layers of mitotically inactivated mouse primary fibroblasts. A
total of 200 colonies were picked and plated onto 96-well plates, grown
for 48 h, trypsinized, and split onto triplicate 96-well plates, one for
freezing and two for screening. Clones were initially screened for Neo
cassette deletion by G418 (180 g/ml) treatment. G418-sensitive clones
were then further screened using a combination of PCR and automated
sequencing. Primers were designed to anneal to a DNA sequence up-
stream of the 5 loxP site and downstream of the 3 loxP site. All Neo-
deleted clones were sequenced to confirm the presence of the L9A mu-
tation. Karyotype analysis was used to assess chromosome number. Two
Neo-deleted L9A 4 clones were injected into C57BL/6 blastocysts, and
chimeras were established.
Chimeras were mated with wild-type animals, and germ-line trans-
mission was established as assessed by PCR analysis of tail DNA and
sequence analysis. To obtain a congenic line, L9Amice have been back-
crossed to C57BL/6J for several generations, currently N7.
[Ca2]imeasurement in thalamic cell cultures.Changes in [Ca
2]i were
measured in thalamic cell cultures using the ratiometric fura-2method as
described previously (Nashmi et al., 2003). Thalamic tissue obtained
from embryonic day 16 embryos was digested with 1 mg/ml papain, and
cells were mechanically separated by gentle pipetting. Cells were plated
onto 35 mm dishes with glass coverslip bottoms in Neurobasal culture
medium containing 2% B27 supplement, 0.5 mM glutamax, and 5%
horse serum, all obtained from Invitrogen (Carlsbad, CA). Cell cultures
were kept in a temperature-, humidity-, and CO2/O2- controlled incu-
bator. Before imaging, cells were loaded with 1.25 M fura-2 AM (In-
vitrogen) in a 0.01% pluronic acid solution for 35 min at room temper-
ature (22  2°C) and in the dark. During experiments, cultures were
continually perfusedwith an extracellular solution (inmM): 150NaCl, 10
HEPES, 10 glucose, 4 KCl, 2 CaCl2, and 2MgCl2. Various channel block-
ers to suppress nonspecific responses were included in the extracellular
solution (in M): 0.5 TTX (voltage-gated Na channels), 0.5 atropine
(muscarinic receptors), 10 CNQX (AMPA and kainate receptors), 20
bicuculline (GABAA receptors), and 50 AP-5 (NMDA receptors). Ascor-
bic acid at 1 M was also added to the extracellular solution to protect
neurons from photodamage. Imaging was performed with an inverted
fluorescence microscope using a 40 oil-immersed objective (UApo/
340, 1.35 numerical aperture; Olympus Optical, Melville, NY). To gen-
erate ratiometric estimates of [Ca2]i, pairs of images were obtained
with alternate excitation wavelengths of 340/380 nm and emission wave-
length of 510 nm.AU-tube connected to a pipette, placed0.5mmaway
from the targeted cell population, was used to deliver nicotine. Nicotinic
receptors desensitize at agonist concentrations too low to cause appre-
ciable activation; therefore, between applications, negative pressure was
maintained on the U-tube to prevent nicotine from leaking out of the
pipette. Nicotine was applied onto cultured cells when solution flow in
the U-tube was momentarily (2 s) reversed by stopping outflow with a
computer-controlled valve. Images were captured with a 16 bit CCD
camera (Photometrics, Tucson, AZ) and analyzed with Slidebook 4.0
imaging software (Intelligent Imaging Innovations, Denver, CO).
Whole-cell patch recordings. To interpret changes in [Ca2]i measured
with ion-sensitive dyes after nicotine or ACh application, one wishes to
decide whether the major Ca2 flux is directly through nAChRs and/or
indirectly through voltage-gated Ca2 channels. This question is usually
addressed by using Ca2 channel blockers. However, concerns arise
about the use of these blockers because of previous reports that they also
interact with nAChRs (Lopez et al., 1993; Donnelly-Roberts et al., 1995).
We therefore studiedCa2 channel blocker–nAChR interactions. Block-
ade of nAChR receptors by calcicludine (750 nM) (Stotz et al., 2000),
nifedipine (30 M) (Shen et al., 2000), and -conotoxin GVIA (2 M)
(Wang et al., 1992) was examined in voltage-clamped L9A thalamic cell
cultures. Calcicludine and -conotoxin were purchased from Alomone
Labs (Jerusalem, Israel). Cultures were prepared and maintained as de-
scribed in the fura-2 experiments.Whole-cell recordingswere performed
with glass electrodes (2–5 M) filled with an internal solution (in mM):
88 KH2PO4, 4.5 MgCl2, 0.9 EGTA, 9 HEPES, 0.4 CaCl2, 14 creatine
phosphate, 4 Mg-ATP, and 0.3 GTP (Tris salt), pH 7.4 with KOH
(Nashmi et al., 2003). Channel blockers to suppress nonspecific re-
sponses were included in the extracellular solution (in M): 0.5 TTX
(voltage gated Na channels), 0.5 atropine (muscarinic receptors), 10
CNQX (AMPA and kainate receptors), 20 bicuculline (GABAA recep-
tors), and 50 AP-5 (NMDA receptors). Recordings were made using an
Axopatch 1D (Axon Instruments) amplifier, low-pass filtered at 2–5
kHz, and digitized on-line at 20 kHz (pClamp8; Axon Instruments). The
membrane potential was held at 70 mV. The 3 M ACh test pulses
lasting 250 ms were delivered with a two-barrel glass theta tube pulled
from borosilicate tubing and connected to a piezoelectric translator
(LSS-3100; Burleigh Instruments Fishers, NY). Calcium channel block-
ers contained in the second barrel of the theta tube were delivered 2 min
after an initial pair of ACh test pulses and a few seconds before a third
pulse. Recovery from block was assessed after a 10 min wash with extra-
cellular solution.
Nicotine-stimulated 86Rb efflux. Nicotine-stimulated 86Rb efflux
from thalamic and cortical synaptosomes of WT, heterozygous (Het),
and homozygous (Hom) mice was measured as described previously
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(Marks et al., 1999). Cortex and thalamus (excluding habenula) were
dissected from adult mice killed by cervical dislocation. Tissue was ho-
mogenized by hand in 1 ml of ice-cold 0.32 M sucrose buffered to pH 7.5
with HEPES using a glass/Teflon tissue grinder. After homogenization,
the grinder was rinsed three times with 0.5 ml of buffered sucrose solu-
tion. A crude synaptosomal pellet was obtained by centrifugation at
20,000  g for 20 min. After removal of the sucrose, each pellet was
resuspended in 0.35ml of load buffer (inmM: 140NaCl, 1.5 KCl, 2 CaCl2,
1 MgSO4, 25 HEPES, and 22 glucose) and placed on ice until incubation
with 86RbCl. Thalamic and cortical synaptosomes were incubated with 4
Ci 86Rb for 30 min in a final volume of 35 l of load buffer, after
which samples were collected by gentle filtration onto a 6-mm-diameter
Gelman type A/E glass filter and washed once with 0.5 ml of load buffer.
Filters containing the synaptosomes loaded with 86Rbwere transferred
to a polypropylene platform and superfused for 5 min with effluent
buffer (inmM): 135 NaCl, 1.5 KCl, 5 CsCl, 2 CaCl2, 1MgSO4, 25 HEPES,
22 glucose, 50 nM tetrodotoxin, and 0.1% bovine serum albumin. A
peristaltic pump applied buffer to the top of the synaptosome containing
filter at a rate of 2 ml/min, and a second peristaltic pump set at a faster
flow rate of 3 ml/min removed buffer from the bottom of the platform.
The greater speed of the second pump prevented pooling of buffer on the
filter. Effluent buffer was pumped through a 200 l Cherenkov cell and
into a -Ram detector (IN/US Systems, Tampa, FL). Radioactivity was
measured for 3minwith a 3 s detection window providing 60 data points
for each superfusion. Each samplewas stimulated by 10 different nicotine
concentrations, with a 5 s exposure for each concentration.
Basal 86Rb efflux was calculated by nonlinear least-squares curve fit
of the samples before and after the nicotine-stimulated peak to a first-
order equation: Ct C0 e
kt, where Ct is baseline counts at time t, C0
is baseline counts at t 0, and k is the first-order constant for basal efflux.
Nicotine-stimulated efflux was calculated as the difference between the
actual sample 86Rb counts after nicotine stimulation and the estimated
basal efflux. Nicotine-stimulated efflux at each concentration was nor-
malized by dividing by the calculated basal efflux; thus, nicotine-
stimulated 86Rb efflux is expressed as the response relative to baseline.
EC50 values were calculated using the following Hill equation: ENIC 
Emax  nic
nH/(nicnH  EC50), where ENIC is the efflux measured after
stimulation with nicotine concentration nic, and nH is the Hill
coefficient.
To evaluate the effects of previous nicotine exposure on nicotine-
stimulated 86Rb efflux (desensitization), synaptosomes prepared from
cortex and thalamus of WT and Hom mice that had been loaded with
86Rbwere superfused for 10minwith buffer containing nicotine before
a 5 s stimulation. WT synaptosomes were treated with one of the follow-
ing nicotine concentrations (in nM): 0, 1, 3, 10, 30, or 100. Hom samples
were treatedwith one of the following (in nM): 0, 0.1, 0.3, 1, 3, or 10. After
treatment with low nicotine concentrations, WT synaptosomes were
stimulatedwith 100Mnicotine, andHom samples were stimulatedwith
10 M nicotine.
125I-Epibatidine binding. Epibatidine binding was used for quantitat-
ing nicotinic receptor levels in various brain regions of WT and L9A
mutant mice as described previously (Whiteaker et al., 2002). Tissue was
collected from the thalamus, cerebral cortex, interpeduncular nucleus,
medial habenula, and hippocampus and homogenized in ice-cold 0.1
binding buffer (in mM): 14.4 NaCl, 0.2 KCl, 0.2 CaCl2, 1 MgSO4, and 2
HEPES, pH7.5.Homogenates werewashed three times by centrifugation
(12,000 g, 15min, 4°C) and resuspension into 0.1 binding buffer and
stored at 70°C. For saturation binding experiments, 125I-epibatidine
concentrations were varied between 3 and 400 pM. The 200 pM 125I-
epibatidine (a saturating concentration) was used in inhibition binding
experiments. Cytisine inhibition of 125I-epibatidine was measured using
drug concentrations of 0.1–3000 nM plus a no-drug control. The amount
of membrane protein added was chosen to produce maximum ligand
binding to the tissue of 1000 Bq/well (5% of total ligand added,
minimizing the effects of liganddepletion) and aminimumof 300 cpmof
specific binding. Membranes were incubated for 2 h at 22°C in 30 l of
binding buffer. Nonspecific binding was determined in the presence of 1
mM ()-nicotine tartrate and fell in the range of 20–50 cpm. Incubations
were terminated by filtration onto Gelman GF/F fiber filters using a cell
harvester, followed by six washes with ice-cold binding buffer. Bound
ligand was measured at 80–85% efficiency using a Packard Cobra
gamma counter (PerkinElmer, Boston,MA). Specific binding was calcu-
lated for each region from every animal by subtraction of the relevant
nonspecific binding value. Saturation binding parameters were calcu-
lated by fitting data to the following Hill equation: B  BmaxL
n/(Ln 
KD
n), whereB is the binding at the free ligand concentration L,Bmax is the
maximum number of binding sites, KD is the equilibrium binding con-
stant, and n is the Hill coefficient. Inhibition of 125I-epibatidine binding
was calculated using a two-site fit: B  B1/(1  (I/IC50–1))  B2/(1 
(I/IC50–2)), where B was ligand bound at inhibitor concentration I, and
B1 and B2 represent 125I-epibatidine binding to sites sensitive to cytisine
inhibition with IC50–1 and IC50–2, (cytisine-sensitive and cytisine-
resistant sites, respectively).
Behavioral studies. In vivo experiments were performed according to
National Institutes of Health and local institutional guidelines for the
humane treatment of laboratory animals. Drug-naive mice, 3–5 months
old, with similar number of females and males and fromN4 through N7
C57BL/6J-backcrossed generations, were used in these experiments. No
statistical differenceswere found betweenN4 andN7 animals of the same
genotype in any of the experiments performed. Nicotine tartrate was
dissolved in saline, with a final concentration adjusted to an injection
volume of 10 l/gm body mass and administered subcutaneously. Nic-
otine doses are expressed asmilligrams of base per kilogramof livemouse
weight. Acute behavioral responses to nicotine were scored by an exper-
imenter unaware of the mouse’s genotype according to a modified be-
havioral scale (Dobelis et al., 2003): no visible response (0), sedation and
loss of locomotion (1), Straub tail and/or shortened gait (2), circling
and/or head bobbing (3), severe tremors, wild running, and/or cornering
(4), loss of righting response and clonic convulsion (5), clonic-tonic
convulsion (6), and tonic hindlimb extension and death (7). Mice with
behavioral scores of 5, 6, or 7 were tabulated as having seizures and used
to calculate seizure onset averages and SEs (see Fig. 6B,D). The following
compounds were tested for their ability to prevent nicotine-induced sei-
zures in L9A and WTmice: (1) carbamazepine, a commonly used anti-
epileptic; (2) dihydro--erythroidine (DHE), a competitive nicotinic
antagonist with high affinity for 4/2 receptors; (3) hexamethonium, a
nicotinic antagonist with poor brain-barrier permeability and thus sus-
pected of preferentially targeting nicotinic receptors in the periphery; (4)
mecamylamine, a potent wide-spectrum nicotinic antagonist, and (5)
nicotine, reported to prevent seizures in an otherwise drug-resistant AD-
NFLE patient (Willoughby et al., 2003). All pretreatment drugs were
dissolved in saline, except for carbamazepine, which was suspended in
1% Tween 80. Dose and delivery schedule of pretreatment drugs are
listed in Table 1, except for nicotine, which is shown in Figure 6,C andD.
The final concentration of pretreatment drugs and the seizure-inducing
nicotine dose were adjusted to an injection volume of 5 l/gm each so
that the total volume of both injections was the same as in single-nicotine
injection experiments. To reduce the number of mice killed in seizure-
inducing experiments, no Hom mice were tested in the nicotine dose–
response pretreatment studies.
In vivo electrophysiology. Electroencephalographic (EEG) recordings
were obtained from freely-moving animals using a low-torque commu-
tator (Dragonfly, Ridgeley, WV). Electrodes were stereotactically im-
planted in mice anesthetized with a ketamine (100 mg/kg) and xylazine
(25 mg/kg) mixture. Field recordings were obtained from (1) stainless
steel screws in the skull (head diameter, 1.5 mm; length, 1.8 mm), used
for monitoring extended cortical regions, or (2) thin depth electrodes
(tungsten, 0.1 mm diameter, 200 k), intended to detect voltage
changes in deeper brain regions. Depth electrodes were inserted unilat-
erally through a hole drilled in the cranium. A ground screw electrode
was placed in the skull away from the other electrodes. A three-pin mi-
croconnector (ground electrode plus two recording electrodes) was ce-
mented to the skull surface with dental acrylic. Electrode placement co-
ordinates in parentheses are expressed in millimeters from bregma, with
the first number corresponding to the anteroposterior axis, the second
representing midline lateral axis, and, in the case of depth electrodes, the
third number representing depth from skull surface. Bilateral screw elec-
trodes were placed in the parietal cortex (2  1.7), the somatosensory
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cortex (1.51.7), theprimarymotor cortex (0.81.1), or thecingulate
cortex (0.1  0.3). Depth electrodes were positioned in the hippocampus
(2, 2, 1.5), the ventral thalamus (1, 1, 3.2), or the insular cortex (0.9, 3.5,
3.6). After surgery,micewere allowed to recover for 5 d. Simultaneous video
and EEG recordings started 10min before and continued for 15min after a
single nicotine injection. Data were acquired with a differential amplifier
(BrownleePrecision,SanJose,CA),witha1kHzsamplingrateandbandpass
filtered at 1–200 Hz. EEG data were analyzed with Clampfit 8.2 software
(Axon Instruments). Video and electroencephalographic signals were digi-
tally synchronized with a Stellate hardware–software system (Stellate Sys-
tems, Montreal, Quebec, Canada). During some EEG recordings, mouse
movements were measured with a piezo film sensor mechanotransducer
(MSI, Fairfield, NJ) connected to the spring-suspended floor panel. The
transducer signal was led to a low-pass Bessel filter (100 Hz, 902 LPF; Fre-
quency Devices, Haverhill, MA) and analyzed with Clampfit 8.2 software.
Chronic EEG recordings.Digitally synchronized video/EEG recordings
lasting 24 h were performed to determine whether L9Amice had spon-
taneous seizures and/or altered sleep–wake patterns. Screw electrodes
were bilaterally implanted above the primary motor cortex (from
bregma, anteroposterior, 0.8; lateral, 1.1 mm). Animals were indi-
vidually housed with food and water and connected to the recording
system through a commutator as described above. Mice were allowed to
acclimate in the recording room for 48 h before data acquisition. EEG
recordings started at 5:00 P.M., and lights were switched off at 8:00 P.M.
and back on at 7:00 A.M. This lights on–off schedule is used by the
California Institute of Technology animal facility, wheremice are housed
from birth. Data were acquired at a sampling rate of 1 kHz, bandpass
filtered at 1–100 Hz, and resampled at 200 Hz. The EEG power spectrum
was computed for overlapping 2.5 s Hanning-windowed intervals (512
points). The vigilance states of five WT, five Het, and four Hom mice
were determined by analyzing EEG power spectral density changes over
time (see Fig. 9). Criteria used to identify periods of rapid eye movement
(REM) sleep, non-REM (NREM) sleep, or wakefulness were based on
previously published reports: REM sleep has a distinct power spectrum
peak at 6–7 Hz, NREM sleep has a peak at 2–4 Hz, and wake has an
overall low power level, with a peak at 6–8 Hz (smaller than REM)
(Franken et al., 1998; Lena et al., 2004). The automated analysis of the
power spectra of each mouse was tuned on the basis of 2 h of simulta-
neousEEG/videorecordings.These recordingsweremanually scored ineach
of three WT, three Het, and two Hom mice as being awake, sleeping, or
having brief movements during sleep; observers were blind to genotype.
Algorithms were implemented inMatlab (MathWorks, Natick, MA).
Mouse locomotion. Mouse locomotion was measured over a 24 h pe-
riod using activity cages with infrared beams (San Diego Instruments,
San Diego, CA). A locomotion event was recorded when two contiguous
beamswere interrupted successively. Locomotion experiments were per-
formed independently from chronic EEG recordings, although housing
conditions were the same. Eight mice from each genotype were allowed
to acclimate in the recording room for 48 h before data acquisition. The
light/dark schedule used was the same as described above. Locomotion
activity was also measured in the same group of mice during 24 h of
continuous light.
Neuroanatomy.Brain sections obtained fromWT andHommice (n
6 per genotype)wereNissl stained for histological analysis (Simmons and
Swanson, 1993). Mice were anesthetized with 2-bromo-2-chloro-1,1,1,-
trifluoroethane and myocardially perfused with PBS containing 0.1%
heparin, followed by 4% paraformaldehyde. Brains were postfixed over-
night with 4% paraformaldehyde and immersed for 2 d in a 30% sucrose
solution for cryoprotection (4°C). 2-Methylbutane in dry ice was used to
rapidly freeze brains, and coronal sections 30 m thick were cut with a
cryostat (Leica, Nussloch, Germany). Alternate sections were mounted
onto glass slides and air dried at room temperature for 24 h. Sectionswere
delipidized with successive ethanol washes (70, 95, and 100%), followed
by a 1 min immersion in xylene. Sections were then rehydrated with
reversed-order ethanol washes, stained with 0.25% thionin, and differ-
entiated with ethanol washes followed by xylene. Finally, glass slides were
coverslipped with a 10:1 Permount/xylene mixture, and brain sections
were examined under an inverted microscope (Olympus Optical).
Results
The L9Amutation increases agonist sensitivity in
Xenopus oocytes
We designed the L9A mutation based on two types of previous
studies. First, experiments on neuronal and muscle nAChR sub-
types expressed in heterologous systems showed that the Leu9
position is crucial for gating (Revah et al., 1991; Filatov and
White, 1995; Labarca et al., 1995). In general, dose–response re-
lationships were shifted to lower agonist concentration by muta-
tions that increase the polarity or hydrophilicity of the 9 side
chain, primarily via increased channel open time (Kearney et al.,
1996; Kosolapov et al., 2000). These studies allowed us to predict
the approximate degree of hypersensitivity in a receptor mutated
at the 9 position.
The second type of experiment involves the phenotype of
knock-in mice bearing such mutations. The homozygous and
hemizygous 7 Leu9Thr mice died within 24 h after birth (Orr-
Urtreger et al., 2000), but the heterozygous mice were viable and
fertile. The homozygous andheterozygous4 L9Smice also died
within 24 h after birth, and the only viable, fertile mice were L9S
heterozygous (containingNeo)with a reducedmutant allele level
of expression (Labarca et al., 2001; Fonck et al., 2003). However,
even L9S-Neo heterozygous mice showed modest deficits of
midbrain dopaminergic neurons (Orb et al., 2004).
Therefore, we sought 4 subunits with a more moderate de-
gree of hypersensitivity.We expected to achieve this goal with a 9
side chain intermediate between the strongly nonpolar WT Leu
and the excessively polar Ser or Thr. We replaced the 9Leu resi-
due with Ala and expressed the mutated neuronal 4 subunit
(L9A) along with WT 2 in oocytes. The L9A mutation in-
creased the nicotine and ACh sensitivity of the mouse 42 nic-
otinic receptor (Fig. 1). The WT EC50 values for nicotine (7 1
M) and ACh (48  8 M) were similar to the values reported
previously for human 42 nicotinic receptors expressed in hu-
man embryonic kidney cells (Buisson and Bertrand, 2001). The
L9A mutation reduced the EC50 for nicotine and ACh by 30-
fold. The L9AEC50 for nicotine was 0.23 0.03M and for ACh
was 0.5 0.1 M. The ACh EC50 for L9S was 0.02 0.001 M.
WT and L9A nicotine Hill coefficients were 1.3 0.1 and 1.1
0.1, respectively. WT, L9S, and L9A ACh Hill coefficients were
0.8  0.1, 1.7  0.2, and 1.2  0.1, respectively. Aside from the
WT ACh concentration–response relationship, all Hill coeffi-
cients were greater than unity and thus do not justify a two-
population fit. A WT Hill coefficient of 0.8 for the ACh concen-
tration–response relationship is consistent with previous results
for heterologously expressed human WT 42 receptors (Buis-
son and Bertrand, 2001), which suggests receptor heterogeneity.
However, fitting the WT ACh data to the sum of two hyperbolic
binding functions yielded a low-affinity component that was
93 3% of the total population and displayed an EC50 of 41 5
M, which resembled the value obtained from the Hill equation
fit of 48  8 M. Consequently, low-affinity receptors formed
most of the WT population in our experiments, and the high-
affinityWT population was too small for a reliable EC50 estimate.
There was no noticeable difference in the health of oocytes ex-
pressing 4(L9A)2 compared with WT 42 receptors.
Importantly, the 4(L9A)2 receptors were, as expected, less
hypersensitive than those containing 4 L9S (Fig. 1D) (rat
cDNAs were studied previously; the mouse 4 L9S cDNAs was
constructed and used for the first time in these experiments). On
a logarithmic scale, the dose–response relationship for the
4(L9A)2 receptor is approximatelymidway between those for
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the 4(L9S)2 and the WT receptors (Fig. 1D). Because we
believe that the lethality of the 7 Leu9Thr (Orr-Urtreger et al.,
2000) and L9S strains arises partially from endogenously active
receptors and/or from activation by choline at concentrations
(10 M) existing in CSF (Labarca et al., 2001), we note that
4(L9A)2 receptors showed little or no spontaneous activation
and little activation (10% of maximal levels) by 10 M choline
(data not shown).
The L9Amutation increases
nicotine-induced desensitization
We studied the effect of the L9A mutation on nicotine-induced
desensitization using the oocyte expression system. Desensitiza-
tion was measured by exposing oocytes to a sustained dose of
nicotine while eliciting responses to brief ACh pulses (Fig. 2A,B).
As reported previously (Jia et al., 2003), recovery from nicotine-
induced desensitization was incomplete despite continuous su-
perfusion with nicotine-free saline for 10min.WT and L9A IC50
values for steady-state desensitization were 22 5 and 8.2 0.5
nM, respectively (Fig. 2C). The WT IC50 was somewhat less than
the previously reported value (61 nM) for rat 42 nicotinic re-
ceptors expressed in oocytes (Fenster et al., 1997). WT and L9A
receptors showed a similar degree of desensitization when rela-
tively low nicotine concentrations were used (for example, at 10
nM nicotine; Student’s t test, p  0.07),
whereas higher nicotine concentrations
causedmore desensitization in L9A than in
WT (for example, at 100 nM nicotine; Stu-
dent’s t test, p 0.006) (Fig. 2C). The L9A
mutation reduced the IC50 for steady-state
nicotine desensitization approximately
threefold compared with a 30-fold reduc-
tion in the EC50 for nicotine activation of the
receptor (Fig. 2D). Hill coefficients for WT
and L9A desensitization were 0.45  0.06
and 1.13 0.06, respectively. A twofold dif-
ference in the Hill coefficient between WT
and L9A desensitization suggests a more
homogenous mutant receptor population.
Themaximum sustained fractional nicotine
response [“window” response (Lester,
2004)], measured from the intersection of
desensitization and activation concentra-
tion–response relationships, occurred at a
lower nicotine concentration for L9A
(40–50 nM) than forWT (1–2M) receptors
(Fig. 2D). Given the uncertainties associ-
ated with measurements of small currents
and with differently shaped dose–response
relationships, it is not possible to compare
the size of the windows for WT versus L9A
receptors quantitatively, but such windows
clearly do occur for both receptors. There-
fore, the L9A mutation increased steady-
state desensitization of the nicotine re-
sponse over a wide range of nicotine
concentrations, and it reduced the nicotine
concentration at which the nicotinewindow
response occurred.
The L9Amutation does not affect ion
selectivity for Na, K, and Ca2
Previous studies show that mutations in the
M2 region can alter the ion selectivity of nicotinic receptors, al-
though mutations at the 2 position appear to have the greatest
effect (Cohen et al., 1992;Wang and Imoto, 1992). To determine
whether the L9Amutation altered ion selectivity of 42 recep-
tors for three physiologically relevant cations (Na, K, and
Ca2), we substituted K or Ca2 for extracellular Na and
measured the shift in reversal potential (Er) of the ACh response
(see Materials and Methods). The L9A mutation did not signif-
icantly change PNa/PK (Student’s t test, p 0.40) or PCa/PK (Stu-
dent’s t test, p 0.98) (Fig. 3). WT and L9A Er values in 98 mM
extracellular Na were 14  2 mV (n  5) and 11  1 mV
(n 5), respectively (Fig. 3A). EquimolarK substitution shifted
WT Er by 8 2mV (n 5) and L9A Er by 7 2mV (n 5) (Fig.
3B), giving a PNa/PK for WT of 0.73  0.02 and 0.76  0.03 for
L9A.This shift implies thatWTandL9Achannelswere 24–27%
less permeable to Na than K. Er values in 65 mM Ca
 were
equal forWT (8 2 mV; n 4) and for L9A (8 3 mV; n 5)
(Fig. 3C). The pooled Er(K) for WT and L9A was 5  1 mV
(n 10), giving an apparent [K]i of 119 3mM (assuming that
K was the sole intracellular permeant cation). Using this value
for [K]i,WT and L9A PCa/PK values were 1.5 0.1 (n 4) and
1.5  0.2 (n  5), respectively. Thus, WT and mutant channels
were 50%more permeable to Ca2 thanK. Dividing the PCa/PK
Figure 1. Nicotine- and ACh-induced responses of mouse WT 42 and 4(L9A)2 receptors expressed in Xenopus
oocytes. The L9A mutation increases nicotine and ACh sensitivity of mouse 42 receptors. A, Nicotine-induced voltage-
clampcurrents recorded fromoocytes expressingmouseWTor4(L9A)2 receptors.B,WTandL9Anicotine concentration–
response relationships, normalized to the maximal response of each oocyte. Lines are fits to the Hill equation. WT and L9A
nicotine EC50 values are 7 1 and 0.23 0.03M, respectively. Hill coefficients are 1.3 0.1 and 1.1 0.1, respectively.
Error bars are SEM; n 8–9. C, ACh-induced voltage-clamp currents recorded from oocytes expressing mouse WT or
4(L9A)2 receptors.D, ACh concentration–response relationships and fits to theHill equation.WT, L9A, and L9S ACh EC50
values are 48 8, 0.5 0.06, and 0.02 0.001M, respectively. Hill coefficients are 0.8 0.1, 1.2 0.1, and 1.7 0.2,
respectively. Error bars are SEM; n 5.
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by PNa/PK gives a PCa/PNa of 2.0 0.1 for
WT and 2.0  0.3 for L9A. These values
are similar to those reported previously
for rat 42 receptors expressed in oo-
cytes (Haghighi and Cooper, 2000).
Thalamic cell cultures obtained from
L9A embryos are hypersensitive
to nicotine
Thalamic neurons were easily distin-
guished from glia in culture: cell bodies of
neurons were elevated, elongated, and
bright, with well defined processes. All
cells identifiable anatomically as neurons
showed increased 340/380 nm fura-2 flu-
orescence ratios at the appropriate nico-
tine concentrations. Thalamic cultured
cells derived from Het and Hom embryos
were more sensitive to nicotine than WT,
as measured by increases in [Ca2]i (Fig.
4). Het and Hom cultures, but not WT
ones, had significant fura-2 responses af-
ter bath application of nicotine at concen-
trations of 0.1 and 1 M (Fig. 4A–C). In
addition, ratiometric measurements
showed a 3.5-fold larger fura-2 response in
Het and Hom compared with WT cells at
saturating nicotine concentrations. There
was no significant difference between Het
and Hom neurons in their sensitivity to
nicotine (ANOVA, p  0.62) (Fig. 4D).
Het and Hom were also more sensitive
and had larger maximal responses than
WT when ACh was applied to the cells
(data not shown). The EC50 values for
WT, Het, and Hom thalamic cultures,
7.1  4.3, 0.2  0.1, and 0.6  0.6 M,
respectively, and 3.5-fold greater maximal
signals for L9A cultures, are close to those
measured previously for WT and L9A
Het neurons inmidbrain cultures (Tapper
et al., 2004). Data in Figure 4 correspond
to cell groups imaged from a single field of
view, from a single Petri dish, and for each
genotype (17WT cells, 22Het cells, and 16
Hom cells). Similar results were obtained
from additional cell cultures derived from
embryos from three WT  WT, four Hom  WT, and two
HomHommatings.
We examined the interaction between calcium channel block-
ers (calcicludine, nifedipine, and -conotoxin) and nAChR ex-
pressed in Hom-derived cell cultures with the ultimate goal of
determining the source of [Ca2]i changes after nicotine or ACh
exposure. ACh-induced currents were measured in voltage-
clamped neurons before and after they were exposed to calcium
channel blockers (Fig. 4E–G). Blockers were tested at concentra-
tions reported to achieve maximal block of L-type and N-type
calcium channels (Wang et al., 1992; Shen et al., 2000; Stotz et al.,
2000). The 30M nifedipine and 2M-conotoxin almost com-
pletely abolished the ACh response, whereas 750 nM calcicludine
diminished it by 67%. Responses recovered incompletely after a
10minwash, presumably because some blocker remained and/or
rundown effects. Thus, these results reinforce the surprising no-
tion that several calcium channel blockers of widely varying
structures also interact directly with nicotinic receptors. Because
we lack a specific agent that blocks Ca2 channels without block-
ing nAChRs, we desisted from using calcium channel blockers to
distinguish between Ca2 entry directly through nAChRs versus
indirectly through voltage-gated calcium channels.
Hypersensitivity of nAChRs in synaptosomes made from
L9A mice
Functional expression of mutated nAChRs in the forebrains of
adult L9A mice was assessed by measuring nicotine-stimulated
86Rb efflux in synaptosomes. Once nAChRs are opened by nic-
otinic ligands, 86Rb can exit the cell (or a synaptosome) much
in the same way potassium does under physiological conditions.
Brief (5 s) exposure to nicotine resulted in a concentration-
dependent increase in 86Rb efflux for both cortical and tha-
Figure 2. Desensitization of mouse WT 42 and 4(L9A)2 receptors expressed in Xenopus oocytes. A, WT and L9A
responses to 200nMAChpulses. Each oocytewas exposed to 13AChpulses, 2.5 s in duration at intervals of 120 s. Immediately after
the third ACh pulse, nicotine was bath applied for 10 min (5 pulses). B, Time course of ACh responses at various nicotine concen-
trations. Data exemplify responses from three or four oocytes tested at each nicotine concentration. L9A valueswere corrected to
account for changes in the sizeof the responsesover time in theabsenceofnicotine (seeMaterials andMethods).No correctionwas
necessary for WT. C, Concentration dependence of desensitization for WT and L9A. Regression lines are fits to a sigmoidal
inhibitory function. IC50 values are 22 5 and 8.2 0.5 nM for WT and L9A, respectively. Hill coefficients are 0.45 0.06 and
1.13 0.06 for WT and L9A, respectively. D, Concentration dependence of desensitization and activation (see Fig. 1B) normal-
ized to maximal response of each oocyte for WT and L9A.
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lamic synaptosomes prepared fromWTmice (Fig. 5A). Maximal
86Rb efflux from thalamic synaptosomes (17  1 relative to
baseline) was significantly greater than that from cortical synap-
tosomes (10  1 relative to baseline). Estimated EC50 values for
nicotine also differed between these regions (7 2M for cortex
and 2.9  0.6 M for thalamus). However, the L9A mutation
affected nicotine-stimulated 86Rb efflux in these two regions
similarly, resulting in a gene–dose-dependent reduction in max-
imal response and a shift to the left (increased sensitivity) of the
concentration–effect curves. Maximal 86Rb efflux in Hom
mice was estimated as 2.1  0.2 for cortex and 4.9  0.1 for
thalamus. Estimated EC50 values for nicotine were lower than the
EC50 values ofWTmice in both brain regions of L9AHommice
(0.1 0.1 and 0.18 0.06 M for cortex and thalamus, respec-
tively). Nicotine-stimulated 86Rb efflux for L9A Het mice was
intermediate between that of WT and Hom mice: maximal
86Rb efflux was 7.0  1.2 and 12.5  0.8, whereas estimated
EC50 values were 2.2  0.7 and 1.0  0.3 M for cortex and
thalamus, respectively. Importantly, despite the reduced maxi-
mal nicotine-simulated 86Rb efflux observed in Hom, the mu-
tation also increased apparent nicotine affinity, resulting in larger
responses for Hom andHet synaptosomes at nicotine concentra-
tions1 M.
Desensitization was assessed in cortical and thalamic synap-
tosomes prepared fromWT and Hom mice. We exposed synap-
tosomes to comparatively low nicotine concentrations and then
measured subsequent nicotine-stimulated 86Rb efflux (Fig.
5B). Much like the reduction seen in the EC50 for agonist-
stimulated 86Rb efflux by the L9A mutation, desensitization
also occurred at lower nicotine concentrations in L9A compared
with WT. The IC50 for desensitization of nicotine-stimulated
86Rb efflux in WT cortical synaptosomes was 16 6.0 nM, and
this value was reduced to 0.93 0.35 nM in Hom. Similarly, the
IC50 for desensitization of nicotine-stimulated
86Rb efflux in
thalamic synaptosomes was reduced from 22  7 nM in WT to
2 0.7 nM in Hom. Thus, in both WT and Hom synaptosomes,
the concentration of nicotine required to desensitize a subse-
quent response to agonist stimulation was at least 100-fold lower
than that required for activation. Both the ability to induce de-
sensitization by previous exposure to low concentrations of nic-
otine and the shift in apparent affinity of nicotine for this process
by the L9A mutation in synaptosomal preparations recall that
observed for receptors expressed in Xenopus oocytes (Fig. 2).
125I-Epibatidine binding
To estimate the effect of the L9A mutation on the expression of
nAChRs, we determined the binding of 125I-epibatidine tomem-
branes prepared from cortex and thalamus ofWT,Het, andHom
mice (Fig. 5C). Saturation curves for 125I-epibatidine indicated
that a gene–dose-dependent reduction in total high-affinity sites
occurred as a consequence of the L9A substitution. Total maxi-
mal binding in cortical membranes decreased from 58  8
fmol/mg protein in WT to 33 3 fmol/mg protein in Het (44%
decrease) to 19  1 fmol/mg protein in Hom (68% decrease).
Similarly, maximal binding in thalamic membranes decreased
from 113  4 fmol/mg protein in WT to 77.7  4 fmol/mg
protein inHet (31%decrease) to 49 2 fmol/mg protein inHom
(57% decrease). Apparent affinity of 125I-epibatidine for these
high-affinity binding sites were also increased slightly by the L9A
mutation (apparent KD values in cortex were 56  3.2, 42  6,
and 38 3 pM and in thalamus were 28 2, 20 2, and 15.2
0.6 pM for WT, Het, and Hom mice, respectively).
The datawere evaluated for the effects of the L9A substitution
on cytisine-sensitive and cytisine-resistant components of 125I-
epibatidine binding (Fig. 5D). Cytisine-sensitive sites, in almost
all brain regions, are thought to correspond primarily to 42*
receptors (Marks et al., 1998). Cytisine inhibition binding data
show that most of the reduction in binding occurred from the
cytisine-sensitive component. For Hom, the average for cortex
and thalamus was 56% of WT levels. In the brain regions ex-
amined,Het displayed cytisine-sensitive 125I-epibatidine binding
that was intermediate betweenWT and Hom. It should be noted
that cytisine-resistant sites comprise a relatively small fraction of
the total 125I-epibatidine binding sites in these brain regions
(4% of the sites in cortex of WT and 5.5% of the sites in
thalamus of WT). WT, Het, and Hom had similar levels of 125I-
epibatidine binding in the presence of cytisine (cytisine-resistant
sites; one-way ANOVA, p  0.12). These sites are thought to
correspond tonon-42 receptors. Thus, cytisine inhibition data
indicate that there was a decrease in the expression of mutated
receptors in the Hom and Het, without apparent changes in the
expression levels of other nAChR subtypes. Analysis of the effects
of the L9A mutation on cytisine-sensitive and cytisine-resistant
sites in interpeduncular nucleus and medial habenula, regions in
which the cytisine-resistant sites are highly expressed, also indi-
cated that the effects of the mutation were confined to cytisine-
sensitive sites. A previous study determined that cytisine-
sensitive, but not cytisine-insensitive, binding was decreased (to
50–60% ofWT levels) in the striatum andmidbrain of Het L9A
mice (Tapper et al., 2004).
L9A nicotine-induced seizures and their suppression by
nicotine pretreatment
All Het and Hom mice injected with 2 mg/kg nicotine displayed
seizures, whereas a dose of 10 mg/kg nicotine was required to
Figure 3. Na and Ca 2 permeabilities relative to K (PNa /PK , PCa /PK ) were measured
for mouse WT42 and4(L9A)2 receptors expressed in frog oocytes. WT and L9A ACh-
induced I–V relationships in 98mM K (A) and 98mMNa (B) between20 and 20mV. The
reversal potentials ofWT and L9A I–V relationships (Er values) were4 and2mV in 98mM
K and10 and11 mV in 98 mM Na, respectively. C, WT and L9A ACh-induced I–V
relationships in65mMCa 2between30and30mV.WTandmutantEr values in65mMCa
2
were 9 and 8mV, respectively. The I–V relationships were obtained from individual oocytes.D,
Relative permeabilities, PNa/PK and PCa/PK, for WT and L9A receptors. Error bars are means
SEM; n 4 oocytes per experiment.
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elicit seizures in allWTmice (Fig. 6A). No
WT mice had seizures when injected with
2mg/kg nicotine; instead, at this dose,WT
displayed sedation and lack of locomo-
tion. ED50 values calculated with a sig-
moid fit were 6.3  0.3, 0.3  0.1, and
0.6  0.3 mg/kg for WT, Het, and Hom,
respectively. In previous studies of the
pharmacokinetics of nicotine and its me-
tabolites, a concentration of1 M nico-
tine was detected in the brains of
C57BL/6J mice injected with 1 mg/kg nic-
otine (Petersen et al., 1984). Based on the
pharmacokinetic data from thePetersen et
al. report, it appears that ED50 values for
nicotine-induced seizure effects in L9A
mice produce brain nicotine concentra-
tions (0.3–0.6 M) near the EC50 values
for L9A receptors in oocytes (Fig. 1B), for
thalamic cultures from L9A mice (Fig.
4D), as well as for 86Rb efflux from L9A
synaptosomes (Fig. 5A). Latency to sei-
zure onset in Het and Hom (44  9 and
43 7 s, respectively, with 2 mg/kg nico-
tine) was much less than in WT (323 
49 s with 10 mg/kg nicotine) (one-way
ANOVA, followed by the Bonferroni’s
test, p  0.001) (Fig. 6B). There was no
strong dose dependence of seizure latency
in either L9A mutants and WT. For ex-
ample, Hommice that received 0.2, 0.5, or
1 mg/kg nicotine had average latencies of
65 20, 51 5, or 57 8 s, respectively
(one-way ANOVA, p 0.62). Seizure du-
ration was estimated by reviewing video
recordings of mice injected with seizure-
inducing doses of nicotine. Seizures in
L9A mice injected with 2 mg/kg nicotine
lasted 28  6 s (n  4), whereas in WT
injected with 10 mg/kg, seizure duration
was 33 12 s (n 5).
Pretreatment with a comparatively small dose of nicotine (0.1
mg/kg) shifted the Het seizure dose–response relationship to the
right (Fig. 6C). Such pretreatment completely blocked 0.2, 0.5,
and 1 mg/kg nicotine-induced seizures in Het mice and shifted
the ED50 from 0.4 0.1 for saline-preinjected mice to 1.9 0.01
mg/kg for nicotine-preinjected mice. Nicotine-pretreated Het
also showed a significant increase in latency to seizure compared
with saline-pretreated animals (at 2 mg/kg; Student’s t test, p 
0.001) (Fig. 6D). Het mice pretreated with 0.1 mg/kg nicotine,
but injected 5 min later (instead of the usual 10 min) with a
second nicotine injection, displayed no seizures either. In con-
trast, seizures in WT were neither blocked nor delayed by nico-
tine pretreatment (2 mg/kg): ED50 values for the saline- and
nicotine-pretreatedWTmicewere 5.0 0.7 and 5.6 0.2mg/kg,
respectively. Pretreatment of WT mice with 0.1 mg/kg nicotine
also failed to prevent seizures or prolong seizure latency. How-
ever, pretreatment with 6 mg/kg nicotine slightly reduced WT
seizure latency compared with saline-pretreated animals (Stu-
dent’s t test, p  0.044) (Fig. 6D). Thus, nicotine pretreatment
blocked or delayedHet seizures but had no effect or hastenedWT
seizures. A modest protective effect by nicotine pretreatment
against nicotine-induced seizures was reported previously in
DBAmice (Miner and Collins, 1988). Discrepancies between the
Miner and Collins study and ours could be attributed to differ-
ences in the mode of nicotine administration, mouse strain used,
or time between nicotine injections.
The antiepileptic drug carbamazepine, injected at a dose of 20
mg/kg and delivered 30 min before a nicotine injection, had a
modest protective effect against nicotine-induced seizures in
WT,Het, andHom(Table 1). In previous studies, carbamazepine
delivered with the same time and dose successfully blocked sei-
zures and/or diminished their effects in mice treated with penty-
lenetetrazole (Borowicz et al., 2003) or strychnine (Yamashita et
al., 2004). The nicotinic antagonists DHE and hexamethonium,
at the doses and time regimens tested, were unable to suppress or
delay nicotine-induced seizures. The DHE dose (3 mg/kg) was
limited by the fact that higher doses cause seizures (Dobelis et al.,
2003). Seizures in mice pretreated with carbamazepine, DHE,
or hexamethonium were similar in intensity, latency, and dura-
tion to those of saline-pretreated animals. Only one dose and
time regimen was tested for each of these drugs; thus, the possi-
bility of successfully blocking seizures at a different dose and/or
schedule remains. That neither DHE nor hexamethonium
blocked seizures could be attributed, amongother possibilities, to
Figure 4. Functional characteristics of nAChRs in thalamic primary cell cultures from WT, Het, and Hom L9A mice. Fura-2
ratiometric [Ca 2]i measurements were made at 2 s intervals, starting 20 s before and ending 80 s after a single application of
nicotine inWT (A), Het (B), andHom (C)-derived cell cultures. Each data point is the average of 17 (WT), 22 (Het), or 16 (Hom) cells.
D, Responses to various nicotine concentrations were used to compose a concentration–response relationship. Het- and Hom-
derived cell cultures were more sensitive and had larger responses to nicotine compared with WT. Whole-cell patch recordings
were obtained from L9A Hom thalamic cell cultures exposed to calcium channel blockers: 750 nM calcicludine (E), 30M nifedi-
pine (F ), and 2M-conotoxin GVIA (G) (n 2 or 3 neurons per blocker). Receptor activity was elicited with 3M ACh test
pulses. After a 10 min wash with extracellular solution, recovery from block was assessed with a final 3M ACh pulse. All three
calcium blockers reversibly decreased ACh responses.
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pharmacokinetic factors, including poor ability to cross the
blood–brain barrier. Seizures were, however, blocked in all mice
pretreated with the nicotinic antagonist mecamylamine (0.5 mg/
kg). Damaj et al. (1999) (see also Dobelis et al., 2003) tested
various doses of DHE, hexamethonium, and mecamylamine to
assess their ability to block nicotine-induced seizures in various
strains of mice. Consistent with our results, these authors found
that only mecamylamine could effectively prevent nicotine-
induced seizures.
EEG, mechanotransducer, and video recordings
During behavioral seizures, no obvious ictal EEG activity was
seen in the traces of Het and Hom mice injected with 2 mg/kg
nicotine (Fig. 7). In contrast, EEGs ofWTmice having behavioral
seizures showed spike-wave discharges after nicotine injection
(10 mg/kg). Spike-wave traces are characterized by events at fre-
quencies ranging from 1 to 5 Hz. Occurrences of spike-wave
during EEG recordings of seizures are typically interpreted as
synchronized firing of neuronal populations in the cerebral
cortex.
Interestingly, Hom mice treated with 10 mg/kg nicotine had
two successive seizures (n 5mice): the first seizure started20
s after nicotine injection, was clonic, and showed no EEG changes
Table 1. Ability of various compounds to block nicotine-induced seizures inWT,
Het, and Hommice
Pretreatment
Behavioral response
mice with seizures
Drug Dose (mg/kg) Timing (min) WT Het Hom
Carbamazepine 20 30 before nic 4 of 6 5 of 6 5 of 6
DHE 3 5 before nic 5 of 5 5 of 5 4 of 4
Hexamethonium 10 10 before nic 5 of 5 5 of 5 4 of 4
Mecamylamine 0.5 10 before nic 0 of 5 0 of 5 0 of 4
After an intraperitoneal injection of the pretreatment drug, mice received a seizure-inducing dose of nicotine (nic):
10mg/kg inWTand1mg/kg inHet andHom.Carbamazepinewas suspended in1%Tween80. Results are expressed
as number of mice that had seizures from total animals tested in each treatment group.
Figure 5. Nicotine-stimulated 86Rb efflux and 125I-epibatidine binding in WT, Het, and
Hom L9A mice. A, 86Rb efflux from synaptosomes made from cortex and thalamus and
stimulatedwith nicotine. Each point is themean SEM; n 7. Lines are the best fit to the Hill
equation.B, Desensitization and activation curves normalized tomaximal response forWT and
L9A synaptosomes. Each point is the mean; n  6 or 7. C, Concentration dependence of
125I-epibatidine binding in the membrane fraction obtained from cortex and thalamus. Each
point is the mean SEM; n 4. D, 125I-Epibatidine binding in cortex and thalamus in the
presence or absence of cytisine was used to calculate cytisine-sensitive sites and cytisine-
resistant sites. Cytisine-sensitive sites are thought to reflect42 receptors. Saturation bind-
ing shows fewer epibatidine binding sites in Het and Hom compared with WT in both brain
regions examined (one-way ANOVA, followed by Bonferroni’s test; §,*p  0.01). Each bar
represents mean and SEM; n 4.
Figure 6. Nicotine-induced seizures and the effect of nicotine pretreatment on seizures. A,
B, Seizures in the absence of pretreatment. Nicotine-induced seizures were expressed as per-
centage of mice that displayed behavioral seizures (A) and time from injection to seizure onset
(B). Mice that did not display seizures 10 min after receiving a nicotine injection were consid-
ered nonresponsive and correspond to data points next to the 600 s mark. Het and Hom were
more sensitive to nicotine thanWT. Each data point inB is themean SEM; n 6. C,D, Effect
of nicotine (nic) pretreatment on nicotine-induced seizures in WT and Het mice. C, Percentage
of seizing mice (as in A); D, time to seizure onset (as in B). Mice were injected with a nicotine
pretreatment dose 10 min before receiving a second test nicotine injection. Nicotine pretreat-
ment (0.1mg/kg) completely blocked seizures in Het that received a second dose of 0.2, 0.5, or
1 mg/kg nicotine. Seizures in WT mice were not blocked by nicotine pretreatment. Each data
point is the mean SEM; n 5.
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(similar to the 2 mg/kg seizures in L9A Het and Hom described
above). The second seizure began 2–4min after the injection, was
tonic-clonic, and had spike-wave discharges (similar to the 10
mg/kg seizures inWTmice described above). The two convulsive
episodes in Hom treated with 10 mg/kg were separated by an
interictal period that varied with each mouse between 1 and 4
min. Synchronized spike-wave discharges were recorded from
both hemispheres ofWTandHom(n 5 per genotype)with two
pairs of screw electrodes bilaterally implanted. Small differences
in the amplitude of spike-wave discharges between the left and
right hemispheres of WT and Hom mice (10 mg/kg nicotine)
were probably caused by variations in the placement of the dif-
ferential and ground electrodes. Only one Het mouse was in-
jected with 10 mg/kg nicotine, because it died after a quick-onset
and violent seizure.
Most EEG recordings were obtained from mice with screw
electrodes positioned on their parietal cortex, above the hip-
pocampus (n 5 per genotype). Other candidate (for ictal activ-
ity) brain regions were also examined with either screw or depth
electrodes in a smaller set of animals (n 2 or 3 mice per brain
location; for coordinates, see Materials and Methods). No spike-
wave discharges were observed in any of the brain regions exam-
ined in L9Amice during seizures with nicotine injections of2
mg/kg. However, modest increases in EEG amplitude and
changes in frequency were detected in the traces of two (of three)
Hets with depth electrodes in their dorsal hippocampus. For ex-
ample, after nicotine injection of 2 mg/kg, there was 158% in-
crease in the amplitude (peak to peak) of the EEG signal com-
pared with the amplitude of the preinjection signal in one Het
male. A WT injected with 2 mg/kg nicotine (no seizure), also
implanted with depth electrodes in the hippocampus, had an
increase in EEG amplitude of 63%. EEGs of all WT mice with
screw electrodes in parietal cortex, somatosensory cortex, or pri-
mary motor cortex, or with depth electrodes in hippocampus or
ventral thalamus, had spike-wave activity during nicotine-
induced seizures.
Because surprisingly few EEG signals accompanied behavior-
ally assessed seizures in mutant mice injected with 2 mg/kg nico-
tine, we sought additional data by making simultaneous electro-
encephalographic and mechanical measurements, the latter with
a mechanotransducer attached to the bottom of the cage (Fig. 8).
There was no simple relationship between muscular activity and
these mechanotransducer records; nonetheless, in both WT and
Hom, the transducer output clearly indicated large movements
during behaviorally assessed convulsions. In WT, movements
detected by the transducer were accompanied by spike-wave ac-
tivity. Power spectral analysis of mechanotransducer traces re-
vealed peaks at 6–7 Hz in two Het and two Hommice while they
were having forelimb clonus. It was not always possible to record
violent rhythmic movements during seizures with the mechano-
transducer because mice sometimes lay on their sides or leaned
against the side panels of the cage.
Animals were also imaged with still and video recordings (Fig.
8) during seizures. WT seizures were characterized by an assort-
ment of movements, with no twomice having the same sequence
of movements. Movement during WT seizures included loss of
righting response, jumping, rearing, limb clonus, and Straub tail
(arching of the tail over the body). Het and Hom seizures dis-
played less variable behavioral patterns during 2 mg/kg nicotine-
induced seizures than the WT group during 10 mg/kg nicotine-
induced seizures. Het andHom seizures were always preceded by
Straub tail (Fonck et al., 2003), followed by loss of the righting
response, and ending with violent forelimb clonus. The distinc-
tion between mutant-like seizures and WT-like seizures was
maintained in Hommice injected with enough nicotine (10 mg/
kg) to provoke both seizure types. Thus, Hommice injected with
10 mg/kg displayed an initial mutant-like seizure (early onset
with forelimb clonus) and a second WT-like seizure (onset 4
min after injection, with various movements and spike-wave
EEGs), with an interictal period of inactivity in between the two
seizures. Within treatment groups, male and female mice had
similar behavioral and electrophysiological responses.
L9Amice have more brief awakenings
Spectral analysis of chronic EEG recordings was used to deter-
mine the fraction of time mice spent awake, in NREM sleep, and
in REM sleep (Fig. 9A). The proportion of time mice spent in
each of these states was similar among genotypes (one-way
ANOVA, p 0.16) and consistent with previously reported val-
ues for mice with a C57BL/6J background (Fig. 9D) (Franken et
al., 1998). Brief movements or twitching events seen during
Figure 7. Traces from EEG recordings of WT, Het, and Hom mice before and after a single
nicotine injection. EEG recordings were obtained from screw electrodes placed on the parietal
cortex (above the hippocampus). During behavioral seizures, no changes were seen in the EEG
traces of Het and Hommice injected with 2 mg/kg nicotine. Recordings fromWT and Hom (10
mg/kg) were obtained from two pairs of screw electrodes bilaterally implanted into left and
right hemispheres. Bilateral and synchronous spike-wave traceswere observed in the EEGofWT
mice injected with 10 mg/kg nicotine during behavioral seizures. Hom mice injected with 10
mg/kg nicotine had two bouts of convulsions separated by an interictal period of 1–3min (72 s
in the example shown). Bilateral and synchronous spike-wave activity was present in the sec-
ond convulsiveburst ofHommice injectedwith10mg/kgnicotine. ThreeWTmicewere injected
with 2 mg/kg nicotine; five animals were tested in each of the remaining treatment groups.
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NREM were accompanied by a decrease in power density. These
behaviorally distinguishable events were labeled “brief awaken-
ings” following previously published nomenclature (Tobler et al.,
1996; Franken et al., 1999) and most likely include and/or are
equivalent to “microarousal” episodes as described by Lena and
et al. (2004). Brief awakenings were behaviorally distinct from
waking episodes because they lasted only a few seconds and mice
did not open their eyes, lift their heads, or move around their
cages. Our analysis showed that Het and Hom mice had more
brief awakenings per hour than WT (Fig. 9B,C). The increment
in brief awakenings seen in L9A compared with WT was evenly
distributed over the light and dark phases. The total fraction of
time mutant mice spent in these brief awakening was  0.3%,
which does not alter significantly the proportion of time mice
spent in the different vigilance states. In addition, Hommice had
30–41% more sleep–wake transitions (excluding brief awaken-
ings) than Het andWT, respectively (one-
way ANOVA, followed by the Tukey’s
pairwise multiple comparison test, p 
0.01).
Mutant and WT mice also differed in
their locomotor activity (Fig. 10). Het and
Hom mice moved around their cages
twice as much as WT during the lights-on
portion of the day (Fig. 10A,C). A similar
difference was noted during 24 h constant
lights-on experiments (Fig. 10B,D).
We sought, but did not find, evidence
for spontaneous seizures in L9Amice. No
clear ictal activity was identified in chronic
EEG recordings of L9A mice. Likewise,
portions of video recordings examined
(2 h/animal) did not show behaviors
that could be construed as convulsive
activity.
Neuroanatomy
Nissl-stained brain sections obtained
fromWT and Hommice were examined
to determine whether expression of the
L9A mutation caused neuroanatomical
abnormalities. The morphology of ma-
jor brain nuclei, including the hip-
pocampus, frontal cortex, midbrain
(ventral tegmental area and substantia
nigra), striatum, thalamus, and cerebel-
lum, was similar between WT and Hom
(images not shown). The absence of
gross abnormalities in the brains of L9A
mice is consistent with the neuroana-
tomical analysis of L9S mice, whose
mutated 4 receptors are even more
sensitive to agonists than L9A ones
(Fonck et al., 2003).
Discussion
L9A mice show a marked increase (15-
fold) in their sensitivity to nicotine-
induced seizures compared with their WT
littermates. Het and Hom L9A mice do
not simply have WT-like seizures at ab-
normally low nicotine concentrations, but
rather, nicotine-induced seizures in L9A
differ qualitatively from those of WT. Temporal, pharmacologi-
cal, electroencephalographic, and behavioral differences between
WT and L9A nicotine seizures strongly suggest the involvement
of distinct neuronal circuits, which are likely determined in each
case by different activation thresholds of4-containing nAChRs.
Many of the nicotine-induced seizure characteristics displayed by
L9A mice are similar to those experienced spontaneously by
ADNFLE patients. Moreover, the L9Amutation caused changes
in receptor function consistent with previous reports of ADNFLE
mutations expressed in Xenopus oocytes.
The major conclusion then is that, when one replaces WT 4
subunits in mice by modestly hypersensitive 4 subunits to pro-
duce hypersensitive 4* nicotinic receptors (predominantly
42), nicotine produces a syndrome with seizures similar to
those experienced spontaneously by 4- or 2-linked human
Figure 8. Traces from simultaneous EEG and mechanotransducer recordings of WT and Hom mice before and after a single
nicotine injection. EEG recordings were obtained from screw electrodes placed on the parietal cortex, on each hemisphere. A
mechanotransducer connected to the bottom of the cage was used to record the frequency and intensity of the mouse’s move-
ments. Photographs were taken during seizures, within the time period of EEG and mechanotransducer traces shown. During
seizures, WT displayed a variety of movements that included jumping, rearing, loss of righting response, and limb clonus; exam-
ples are shown in the photographic sequence. L9Amice seizures were characterized by Straub tail, loss of righting response, and
violent and repetitivemovements of the forelimbs. n 4mice per genotype.WT andHommice shown in the photographs are N4
littermates.
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ADNFLE. Together with anecdotal evi-
dence that 4- and 2-knock-out mice
show neither spontaneous nor enhanced
nicotine-induced seizures, these data leave
little doubt that human 4- or 2-
associated ADNFLE is caused by enhanced
42 receptor activity.
Effects of the L9Amutation on receptor
function and expression
Experiments in oocytes show that the 4
L9A mutation increases the sensitivity of
the mouse 42 nicotinic receptor to
nicotine-induced activation and desensiti-
zation. However, it does not affect ion se-
lectivity of the channel for physiologically
relevant cations, Na, K, and Ca2. We
predicted that L9A would increase recep-
tor agonist sensitivity based on previous
studies showing that the 9 position is crit-
ical for gating and that hydrophilic substi-
tutions increase open-channel time (La-
barca et al., 1995; Kearney et al., 1996;
Kosolapov et al., 2000). All known
ADNFLE-associated mutations in the 4
subunit (S6F, S10L, L18, and T19I)
also increase agonist sensitivity of 42
nAChR (Bertrand et al., 2002; Leniger et
al., 2003). Enhanced desensitization was
also reported in the ADNFLE S6F muta-
tion (Weiland et al., 1996; Bertrand et al.,
2002).
Our fura-2 and nicotine-stimulated
86Rb efflux results indicate that the fore-
brains of L9Amice express hypersensitive
nAChRs. This hypersensitivity, as evi-
denced by leftward shifts in nicotine EC50
values, was expected from, and is consis-
tent with, the oocyte expression data. We
measured actual receptor expression levels
by an appropriately direct method: epiba-
tidine binding in brain tissue homogenates. We found a gene–
dose-dependent decrease in such binding in L9A mice. How-
ever,HomandHet had similarmaximumresponses for nicotine-
induced [Ca2]i increases in cultured thalamic neurons,
86Rb
release in synaptosomes, and seizures in mice. These results run
contrary to the expectation that Hom would be more sensitive
than Het mice.
Other experiments (to be reported elsewhere) show that nor-
mally sensitive 4* receptors, still containing the 42 bp loxP site
plus associated restriction site in a neighboring intron, are ex-
pressed at normal levels in knock-in mice. Hence, the modestly
decreased binding level (less than twofold) does not occur be-
cause of a molecular genetic artifact associated with construction
of the mouse strain. We speculate that the decrement in L9A
receptor expression in vivo arises because of homeostatic mech-
anisms that respond to hyperactive receptors. If this suggestion is
correct, mice are able to compensate functionally for this hyper-
activity: they show seizures only after nicotine injections. Hu-
mans with 4*- or 2*-linked ADNFLE compensate slightly less
completely: they have subtle seizures that escaped clinical de-
scription until 1994 (Scheffer et al., 1994).
Nicotine-induced seizures: type, sensitivity,
and pharmacology
Comparison of the EEG recordings and behavior between WT
and L9Amice suggests the recruitment of distinct neuronal pop-
ulations during nicotine-induced seizures. Importantly,
nicotine-induced seizures in WT are generalized: they show
spike-wave activity in all cortical locations examined, are initi-
ated simultaneously in each hemisphere, and involve violent
whole-body movements. Whereas WT mice display spike-wave
EEG during seizures (10 mg/kg nicotine), L9A (2 mg/kg) show
no recognizable ictal activity with electrodes positioned at vari-
ous cortical locations. Previous studies with anesthetized rabbits
suggest that nicotine-induced seizures leading to spike-wave dis-
charges originate in the hippocampus (Floris et al., 1964; Stumpf
and Gogolak, 1967). We cannot rule out WT seizures with sec-
ondary bilateral synchrony in which there is rapid generalization
from one or multiple foci, one of which could be the hippocam-
pus. Nicotine-induced seizures in L9Amice can be characterized
as partial because they were electrophysiologically subtle or un-
detectable in the cortex, and movements were limited to loss of
righting response and forelimb clonus. Except for modest in-
creases in the amplitude of the EEGs of two Het mice with depth
Figure 9. Chronic EEG recordings in WT, Het, and Hom mice. A, Example of an EEG trace with its corresponding spectrogram
from a WT mouse. Power density (in square microvolts per Hertz) changes in the spectrogram are represented by the color
intensity of individual pixels: dark colorationmeans high-power density. The vigilance state of eachmousewas determinedwith
an algorithm that analyzed power spectrum changes over time. The blue line above the spectrogram represents the output of the
program. B, Brief awakenings were recorded during 13 h with lights on and 11 h with lights off. C, Number of brief awakening
events per hour. Het and Hom mice had more brief awakenings than WT (one-way ANOVA, followed by the Tukey’s pairwise
multiple comparison test, *p 0.001). Each bar represents themean and SEM; n 5 (WT), 5 (Het), and 4 (Hom).D,Wake, NREM
sleep, and REM sleep events were quantified in WT, Het, and Hommice over a 24 h period.
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electrodes in their hippocampus, we were unable to discover the
focaloriginofL9Aseizuresat2mg/kgnicotine.Behavioralpatterns,
homogenous and repetitive inHet andHomandcomplex andpoly-
morphic in WT, suggest the involvement of more limited cortical
motor control areas during L9A seizures than in WT ones. Differ-
ences in the average seizure latency, 43 s in L9A but 323 s in WT
mice, are also consistent with distinct seizure mechanisms.
Nicotine pretreatment blockedmutant, but notWT, seizures.
In oocytes and synaptosomes, nicotine caused more desensitiza-
tion in L9A receptors compared with WT ones. Thus, nicotine
pretreatment of mice appears to act by desensitizing most L9A
nAChRs and rendering themunresponsive to additional nicotine
stimulation (small window activation, on the order of 1%, occurs
even at steady-state desensitization). This suggests that nicotine-
induced seizures in L9Amice are initiated by the activation, not
desensitization, of mutated hypersensitive 4* nAChRs. A simi-
lar mechanism could account for the effects of nicotine on an
ADNFLE patient resistant to conventional antiepileptic drugs (in-
cluding carbamazepine) but successfully treated with a nicotine
patch (Willoughby et al., 2003). That nicotine pretreatment did not
prevent nicotine-induced seizures in WT mice suggests a different
seizuremechanism, perhaps involving desensitization of4* recep-
tors on inhibitory interneurons, leading to neuronal synchroniza-
tion and to overexcitation (Mody, 1998; Dobelis et al., 2003).
Although nicotine-induced seizures in L9A mice are most
likely mediated by 4* receptors, it is not clear what role, if any,
these receptors play in WT seizures. Because higher nicotine
doses are required, we speculate that different nAChR subtypes
are activated (and or desensitized) during WT seizures. Indeed,
studies on knock-out mice indicate that other nicotinic subunits
(3,5, and4) aremore important than those containing4 in
mediating nicotine seizures inWT (Kedmi et al., 2004; Salas et al.,
2004). Although there are no published reports on the nicotine-
induced seizure phenotype of 4 knock-out mice, we recently
found that these mice are similar to their WT littermates in their
sensitivity to nicotine seizures (our unpublished data). In con-
trast to4 knock-outmice, but similar to L9Amice, mouse lines
engineered to express ADNFLE mutationsL264 and S252F are
reportedly hypersensitive to nicotine-induced seizures (Klaassen
et al., 2004).
Sleep disruptions
Chronic EEG recordings revealed a significant increase in the
number of brief awakenings during NREM sleep in L9A com-
pared withWTmice. This result follows the trend of recent find-
ings that knock-out mice lacking the 2 subunit (the major part-
ner of 4) showed less microarousals and sleep–wake transitions
during NREM (Lena et al., 2004). Our results support a role for
4-containing nAChRs in maintaining the structure of NREM
sleep. In humans, ADNFLE seizures and transient arousals typi-
callymanifest during the same light sleep period (phase 2).More-
over, until a decade ago, ADNFLE patients were misdiagnosed
with childhood onset parasomnia, which is a condition that has
also been associated with frequent arousals and a consequent
fragmentation of NREM sleep (Scheffer et al., 1994; Zucconi and
Ferini-Strambi, 2000). These authors suggest that similar mech-
anismsmay underlie excessive transient awakenings during sleep
and nocturnal frontal lobe epilepsies and parasomnias. Increased
locomotion in L9A compared with WT mice during lights-on
hours may be another indication that sleep–wake patterns are
altered as a consequence of expressing gain-of-function 4-
containing nAChRs.
Similarities with ADNFLE
In contrast to WT, nicotine-induced seizures in L9A Het and
Hom mice share a number of features with seizures experienced
by ADNFLE patients. (1) ADNFLE seizures are typically charac-
terized by repetitive jerky limb movements and asymmetrical
posturing (Scheffer et al., 1995) (for review, see Combi et al.,
2004). Nicotine seizures in L9A mice consist of forelimb clonus
and loss of righting response (which can also be described as
asymmetrical posturing). (2) Nicotine suppressed ADNFLE sei-
zures in the single patient tested to date (Willoughby et al., 2003).
Nicotine pretreatment blocked nicotine-induced seizures in
L9Amice. (3) Carbamazepine, which remains the drug of choice
in treating ADNFLE, is ineffective in a significant proportion of
patients (Oldani et al., 1998). Furthermore, amajority of patients
with the S10Lmutation, adjacent to the 9 position, are resistant
to carbamazepine treatment (Ito et al., 2000; Cho et al., 2003). At
the dose tested, carbamazepine had amodest effect in preventing
nicotine-induced seizures in L9A mice. (4) Another important
Figure 10. Locomotion of L9A andWTmice. Locomotion wasmeasured for 24 h in activity
cageswith infrared beams. Each event was defined as two successive beambreaks.A, Locomo-
tion was recorded during 13 h with lights on and 11 h with lights off. B, Locomotion recorded
with lights on for 24h.C, Average locomotionactivitywas larger inHet andHommice compared
withWT during lights-on period asmeasured inA (each bar represents themean and SEM; n
8; one-way ANOVA, followed by the Tukey’s pairwise multiple comparison test, *p 0.05). D,
Average locomotion activity was larger in Het and Hommice compared with WT during a 24 h
continuous lights-on experiment (each bar represents the mean and SEM; n 8; Kruskal–
Wallis test, followed by the Tukey’s pairwise multiple comparison test, *p 0.01). The same
animals were studied in experiments A and B.
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parallel between ADNFLE and nicotine seizures in L9A mice is
that 70% of ADNFLE patients have nondiagnostic EEGs
(Scheffer et al., 1995; Oldani et al., 1998; Rozycka et al., 2003) (for
review, see Combi et al., 2004). Nicotine seizures in L9A were
undetected by EEG. Thus, the absence of interictal or ictal EEG
activity during chronic recordings of L9A mice should be con-
sidered inconclusivewith regards to the occurrence (or lack of) of
spontaneous seizures, but many hours of observations also re-
vealed no obvious seizures in L9A animals. (5) L9Amice, how-
ever, had abnormal NREM sleep with excessive brief awakenings.
Many ADNFLE patients also suffer from altered sleep–wake pat-
terns (Oldani et al., 1998; Roberts, 1998).
No existing study satisfactorily explains the pathophysiology
of even a monogenic human seizure disorder, much less that of a
polygenic disorder. This situation contrasts with the straightfor-
ward pathophysiology of monogenic channelopathies in other
organs: long QT syndrome, hyperinsulinemia, and cystic fibrosis
(Ashcroft, 2000). Our results do, however, serve a more modest
purpose: we emphasize the usefulness of iterative experiments
comparing the biophysical properties of heterologously ex-
pressed receptors with the phenotype of the corresponding
knock-inmice. The sequence involved biophysical analysis of the
Leu9Ser mutation, study of the corresponding knock-in mice
(Labarca et al., 2001; Fonck et al., 2003), design of the Leu9Ala
mutation, and study of the corresponding knock-in mice. Such a
program allows one to target a precise set of receptors, with the
consequent activationof specific brain circuits, which in turn trigger
unique behavioral responses. We conclude that 4- or 2-linked
ADNFLE arises from excessive activation of 42 nAChRs.
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